James Altucher
Contributor since: 2010
Company: Formula Capital
Five Stock For The New Abnormal
Stocks: The Good, The Bad, And The Ugly
Fight Or Flight Investing
Financial Fridays: The Stock Market Is Lying
James Altucher: Why The Stock Market Is A Sucker's Game Right Now (And Which Stocks I Own)
Could Neonode Be An Acquisition Candidate? (And Other Stock Updates)
Why Apple Is Still A Buy Even Though Amazon And Google Have Better Products
Vringo: Could It Be Worth $2 Billion?
What Is Vringo Worth?
Vringo: What Has Happened And What I Think Will Happen
Google Vs. Vringo: Vringo Delivers A Knockout In Round One
Trovagene: The 1 Stock That Could've Saved Steve Jobs' Life
Did Steve Jobs Steal The iPhone From This Potential $30 Stock?
New Catalyst That Could Take Synergy Pharma From $4 to $40
Why Synergy Pharmaceuticals Could Go From $4 to $40
Star Scientific Just Announced They Cured Alzheimer's Disease and Nobody Cares
Giant Interactive: The Cheapest Stock in China
Inhibitex: A Biotech Gem in the Enormous Hepatitis C Market
Latest Developments in the Pharmathene-SIGA Case Point to a Strong Buy for PIP
The Best Biotech Arbitrage Opportunity Right Now
How Ben Bernanke Is Helping Me Profit From QE2
11 Reasons Why the Gold Bubble Will Burst
A Simple, First-Day-of-the-Month, Trading System for ETFs
How Much Money Do You Actually Need to Retire?
Why Pharmathene Could Go From $2 to $20
Why China Stocks Trade So Cheap (And Which Stocks Should Fly)
My Four Step Plan to Save the Economy
Seven Reasons Why There Is No Double Dip
Why I'm Still a Buyer of Just One Gold Stock
4 Stocks That Will Go Up Because of the 60-Mile Traffic Jam in China
3 Stocks That Will Go Up in a Double-Dip Recession
Five China Stocks I'm Buying
The Only Gold Stock I'm Buying
27 Reasons This Rally Is for Real
Did Star Scientific Just Find a Cure for Alzheimer's Disease?
The Best Stock Under $5
8 Companies That Will Benefit From Cisco's 'Internet 2.0' Initiative
Six Things Warren Buffett's Annual Letter Didn't Say
Why the Bank Bailouts Were Necessary